Transplantation of olfactory mucosa following spinal cord injury promotes recovery in rats Koichi Iwatsukia , Toshiki Yoshiminea , Haruhiko Kishimaa , Masanori Aokia , KazuhiroYoshimuraa , Masahiro Ishiharaa , Yuichiro Ohnishia and Carlos Limab aDepartment of Neurosurgery , Osaka UniversityMedical School , Suita , Osaka , Japan and bLaboratory of Neuropathology , Department of Neurology , Hospital de Egas Moniz , Lisbon , Portugal Correspondence to Koichi Iwatsuki , MD , Department ofNeurosurgery , Osaka UniversityMedical School 2-2 Yamadaoka , Suita , Osaka 565-0871 , Japan Several recent studies have demonstrated the potential therapeutic role of olfactory ensheathing cells in spinal cord injury.The aim of this study	1
Transplantation	1
olfactory mucosa following spinal cord injury promotes recovery in rats Koichi Iwatsukia , Toshiki Yoshiminea , Haruhiko Kishimaa , Masanori Aokia , KazuhiroYoshimuraa , Masahiro Ishiharaa , Yuichiro Ohnishia and Carlos Limab aDepartment of Neurosurgery , Osaka UniversityMedical School , Suita , Osaka , Japan and bLaboratory of Neuropathology , Department of Neurology , Hospital de Egas Moniz , Lisbon , Portugal Correspondence to Koichi Iwatsuki , MD , Department ofNeurosurgery , Osaka UniversityMedical School 2-2 Yamadaoka , Suita , Osaka 565-0871 , Japan Several recent studies have demonstrated the potential therapeutic role of olfactory ensheathing cells in spinal cord injury.The aim of this study	20
olfactory mucosa	20
spinal cord injury promotes recovery in rats Koichi Iwatsukia , Toshiki Yoshiminea , Haruhiko Kishimaa , Masanori Aokia , KazuhiroYoshimuraa , Masahiro Ishiharaa , Yuichiro Ohnishia and Carlos Limab aDepartment of Neurosurgery , Osaka UniversityMedical School , Suita , Osaka , Japan and bLaboratory of Neuropathology , Department of Neurology , Hospital de Egas Moniz , Lisbon , Portugal Correspondence to Koichi Iwatsuki , MD , Department ofNeurosurgery , Osaka UniversityMedical School 2-2 Yamadaoka , Suita , Osaka 565-0871 , Japan Several recent studies have demonstrated the potential therapeutic role of olfactory ensheathing cells in spinal cord injury.The aim of this study	47
spinal cord injury	47
recovery in rats Koichi Iwatsukia , Toshiki Yoshiminea , Haruhiko Kishimaa , Masanori Aokia , KazuhiroYoshimuraa , Masahiro Ishiharaa , Yuichiro Ohnishia and Carlos Limab aDepartment of Neurosurgery , Osaka UniversityMedical School , Suita , Osaka , Japan and bLaboratory of Neuropathology , Department of Neurology , Hospital de Egas Moniz , Lisbon , Portugal Correspondence to Koichi Iwatsuki , MD , Department ofNeurosurgery , Osaka UniversityMedical School 2-2 Yamadaoka , Suita , Osaka 565-0871 ,	75
recovery	75
rats	87
Koichi Iwatsukia , Toshiki Yoshiminea , Haruhiko Kishimaa , Masanori Aokia , KazuhiroYoshimuraa , Masahiro Ishiharaa , Yuichiro Ohnishia and Carlos Limab aDepartment of Neurosurgery	93
Koichi Iwatsukia	93
Toshiki Yoshiminea	111
Haruhiko Kishimaa	131
Masanori Aokia	150
KazuhiroYoshimuraa	166
Masahiro Ishiharaa	186
Yuichiro Ohnishia	206
Carlos Limab aDepartment of Neurosurgery	228
Carlos Limab aDepartment	228
Neurosurgery	256
Osaka UniversityMedical School	269
Suita , Osaka , Japan and bLaboratory of Neuropathology	301
Suita , Osaka , Japan and bLaboratory	301
Neuropathology	339
Department of Neurology	355
Department	355
Neurology	369
Hospital de Egas Moniz	380
Lisbon	404
Portugal Correspondence to Koichi Iwatsuki	412
Portugal Correspondence	412
Koichi Iwatsuki	439
MD	455
Department ofNeurosurgery	459
Osaka UniversityMedical School 2-2 Yamadaoka	485
Suita	531
Osaka 565-0871	537
Japan Several recent studies have demonstrated the potential therapeutic role of olfactory ensheathing cells in spinal cord injury.The aim of this study	553
Japan	553
Several recent studies	561
the potential therapeutic role of olfactory ensheathing cells	602
the potential therapeutic role	602
olfactory ensheathing cells	636
spinal cord injury.The aim of this study	667
spinal cord injury.The aim	667
this study	697
elucidatewhether grafts of nasal olfactorymucosa	715
elucidatewhether grafts	715
nasal olfactorymucosa	742
olfactory ensheathing cells	775
the injured rat	814
spinal cord	830
the nasal respiratory mucosa containing no olfactory ensheathing cells	859
the nasal respiratory mucosa	859
no olfactory ensheathing cells	899
These grafts	931
the partially removed rat spinal cord.Compared with the respiratory mucosa-transplanted rats , the olfactory mucosa	972
the partially removed rat spinal cord.Compared with the respiratory mucosa-transplanted rats	972
the partially removed rat	972
spinal cord.Compared with the respiratory mucosa-transplanted rats	998
spinal	998
the respiratory mucosa-transplanted rats	1024
the olfactory mucosa	1066
transplanted rats	1088
the movement of their hindlimbs and joints.Corticospinal tracing	1126
the movement of their hindlimbs	1126
the movement	1126
their hindlimbs	1142
joints.Corticospinal tracing	1162
joints.Corticospinal	1162
olfactory mucosa transplantation	1206
the severed tract	1248
olfactory mucosa	1278
potential value in the repair of spinal cord injury	1299
potential value	1299
the repair of spinal cord injury	1318
the repair	1318
spinal cord injury	1332
Introduction Olfactory ensheathing cells	1353
their potential in the repair of spinal cord injuries -LSB- 1 -- 4 -RSB-	1416
their potential	1416
the repair of spinal cord injuries -LSB- 1 -- 4 -RSB-	1435
the repair	1435
spinal cord injuries -LSB- 1 -- 4 -RSB-	1449
spinal cord injuries	1449
1 -- 4	1471
all these experiments	1489
olfactory ensheathing cells	1512
the olfactory bulb	1560
the embryo	1596
human spinal therapy	1625
major ethical and technical concerns	1647
the use of embryonic tissues or tissues obtained from the brains of adult donors	1704
the use	1704
embryonic tissues or tissues obtained from the brains of adult donors	1715
embryonic tissues or tissues	1715
the brains of adult donors	1758
the brains	1758
adult donors	1772
These difficulties	1786
the olfactory ensheathing cells	1833
nasal olfactory mucosa	1870
This study	1894
grafts of the nasal olfactory mucosa containing olfactory ensheathing cells	1930
grafts	1930
the nasal olfactory mucosa containing olfactory ensheathing cells	1940
the nasal olfactory mucosa	1940
olfactory ensheathing cells	1978
the injured rat	2017
spinal cord	2033
those	2062
several nonolfactory cell types such as fibroblasts , endothelium , and peripheral nerves	2079
several nonolfactory cell types	2079
fibroblasts , endothelium , and peripheral nerves	2119
fibroblasts	2119
endothelium	2132
peripheral nerves	2149
olfactory ensheathing cells	2179
we	2217
the functional recovery of the animals using the well-established Basso , Beattie , and Bresnahan Locomotor Rating Scale -LRB- BBB scoring system -RRB-	2229
the functional recovery	2229
the animals using the well-established Basso , Beattie , and Bresnahan Locomotor Rating Scale	2256
the animals	2256
the well-established Basso , Beattie , and Bresnahan Locomotor Rating Scale	2274
the well-established Basso	2274
Beattie	2302
Bresnahan Locomotor Rating Scale	2315
BBB scoring system	2349
BBB	2349
system	2361
5 -RSB-	2370
Immunohistochemistry	2374
anatomical evidence of olfactory ensheathing cells	2420
anatomical evidence	2420
olfactory ensheathing cells	2443
the grafted site	2474
anterograde corticospinal tract tracing study	2496
anterograde corticospinal tract	2496
study	2536
the regrowth of axons	2570
the regrowth	2570
axons	2586
Materials and methods	2594
Materials	2594
methods	2608
Spinal cord injury Female Sprague -- Dawley rats weighing 250 -- 300 g were anesthetized using a ketamine/rompun mixture	2616
Spinal cord injury Female Sprague	2616
Dawley rats	2650
250	2671
300 g	2675
a ketamine/rompun mixture	2705
90/10 mg/kg , intraperitoneally	2732
90/10 mg/kg	2732
The rectal temperature	2765
37 ± 0.5 °C	2806
37 ±	2806
0.5 °C	2809
a heating pad	2820
The skin and the muscles of the back	2835
The skin	2835
the muscles of the back	2848
the muscles	2848
the back	2863
the thoracic -LRB- Th -RRB- 8 -- 9 vertebrae	2895
the thoracic -LRB- Th -RRB- 8	2895
Th	2909
9 vertebrae	2915
A laminectomy	2928
Th 8 -- 9 using a microsurgery bone rongeur	2959
Th 8	2959
9 using a microsurgery bone rongeur	2964
9	2964
a microsurgery bone rongeur	2972
the spinal cord	3005
it	3050
A 1.5-mm gap	3054
excision of a 1.5-mm region of the spinal cord	3082
excision	3082
a 1.5-mm region of the spinal cord	3094
a 1.5-mm region	3094
the spinal cord	3113
microscissors	3135
Dissection and preparation of the olfactory and respiratory mucosa Adult Sprague -- Dawley rats	3150
Dissection and preparation	3150
the olfactory and respiratory mucosa Adult Sprague -- Dawley rats	3180
the olfactory and respiratory mucosa Adult Sprague	3180
Dawley rats	3231
sodium pentobarbital -LRB- 100 mg/kg -RRB-	3274
sodium pentobarbital	3274
100 mg/kg	3296
decapitation	3325
The nasal septum	3339
the lower jaw , upper teeth , and nasal turbinates	3378
the lower jaw	3378
upper teeth	3393
nasal turbinates	3410
Both olfactory and respiratory mucosae	3428
the septum	3486
The olfactory mucosa	3498
its dorsocaudal portion	3534
the yellowish appearance of its surface	3588
the yellowish appearance	3588
its surface	3616
The respiratory mucosa	3629
located ventrorostral	3656
the olfactory mucosa	3681
the grayish color of its surface	3720
the grayish color	3720
its surface	3741
Each mucosa	3754
the border region between the mucosae	3801
the border region	3801
the mucosae	3827
contamination	3848
Transplantation of the olfactory and respiratory mucosa	3863
Transplantation	3863
the olfactory and respiratory mucosa	3882
transplantation	3926
both mucosae	3943
approximately 0.5-mm to 1.0-mm sections	3970
approximately 0.5-mm	3970
1.0-mm sections	3994
four to six sections of the olfactory and respiratory mucosa	4017
four to six sections	4017
the olfactory and respiratory mucosa	4041
the cavity made in the spinal cord to fill it	4104
the cavity	4104
the spinal cord	4123
it	4147
Seven animals	4151
transplants of the olfactory mucosa and seven control animals	4174
transplants	4174
the olfactory mucosa and seven control animals	4189
the olfactory mucosa	4189
seven control animals	4214
transplants of the respiratory mucosa	4245
transplants	4245
the respiratory mucosa	4260
The wound	4284
the muscle and the skin	4317
the muscle	4317
the skin	4332
the exposed spine	4352
Behavioral assessment The BBB score	4371
Behavioral assessment	4371
The BBB score	4393
an operationally defined 21-point scale	4410
It	4451
the hindlimb locomotor recovery	4476
impact injury	4514
the thoracic cord in rats -LSB- 5 -RSB-	4531
the thoracic cord	4531
rats -LSB- 5 -RSB-	4552
rats	4552
5 -RSB-	4558
These BBB scores	4562
two observers , who were blinded to this study	4598
two observers	4598
this study	4633
the scores	4649
the olfactory and respiratory mucosatransplanted groups using the Student 's t-test for these unpaired results	4695
the olfactory and respiratory mucosatransplanted groups	4695
the Student 's t-test for these unpaired results	4757
the Student 's t-test	4757
the Student 's	4757
these unpaired results	4782
Statistical significance	4806
P	4842
Histological assessment The animals	4850
Histological assessment	4850
The animals	4874
100 ml of 4 % paraformaldehyde in 0.2 M phosphate-buffered saline -LRB- PBS -RRB- , followed by perfusion with 20 ml of PBS	4920
100 ml	4920
4 % paraformaldehyde in 0.2 M phosphate-buffered saline -LRB- PBS -RRB- , followed by perfusion with 20 ml of PBS	4930
4 % paraformaldehyde	4930
0.2 M phosphate-buffered saline -LRB- PBS -RRB-	4953
0.2 M phosphate-buffered saline	4953
PBS	4985
perfusion	5003
20 ml of PBS	5018
20 ml	5018
PBS	5027
The spinal cord encompassing the transplantation site	5032
The spinal cord	5032
the transplantation site	5061
post fixed for 2 h in the same fixative , cryoprotected in 30 % sucrose , and prepared for cryosectioning	5099
post	5099
2 h in the same fixative	5114
2 h	5114
the same fixative	5121
30 % sucrose	5157
The spinal cord	5203
20-µm thick sections	5252
5 % normal goat serum and 0.3 % Triton-X in PBS	5308
5 % normal goat serum	5308
0.3 % Triton-X in PBS	5333
0.3 % Triton-X	5333
PBS	5350
the sections	5355
a primary antibody	5388
a mouse monoclonal antibody raised against p75NGFR -LSB- Chemicon , Temecula , California , USA , Cat	5410
a mouse monoclonal antibody	5410
p75NGFR -LSB- Chemicon , Temecula , California , USA , Cat	5453
p75NGFR	5453
Chemicon , Temecula , California , USA , Cat	5462
No	5504
MAB365 ; dilution , 1 : 500 in 0.1 M PBS -LRB- pH 7.4 -RRB- -RSB- and glial fibrillary acidic protein -LRB- dilution , 1 : 100 ; cow polyclonal antibody ; Dako , Produktionsveg , Glostrup , Denmark -RRB- .	5508
MAB365	5508
dilution , 1 : 500 in 0.1 M PBS -LRB- pH 7.4 -RRB- -RSB- and glial fibrillary acidic protein -LRB- dilution , 1 : 100 ; cow polyclonal antibody ; Dako , Produktionsveg , Glostrup , Denmark -RRB-	5516
dilution	5516
1 : 500 in 0.1 M PBS -LRB- pH 7.4 -RRB- -RSB-	5526
1 : 500	5526
0.1 M PBS -LRB- pH 7.4 -RRB- -RSB-	5537
pH 7.4	5547
glial fibrillary acidic protein -LRB- dilution , 1 : 100 ; cow polyclonal antibody ; Dako , Produktionsveg , Glostrup , Denmark -RRB-	5560
glial fibrillary acidic protein	5560
dilution , 1	5593
dilution	5593
1	5603
100 ; cow polyclonal antibody ; Dako , Produktionsveg , Glostrup , Denmark	5607
100	5607
cow polyclonal antibody	5612
cow	5612
polyclonal antibody	5616
Dako , Produktionsveg , Glostrup , Denmark	5637
the following day	5682
sections	5701
PBS	5727
20 min in secondary antibody -LSB- goat anti-mouse IgG -LRB- H + L -RRB- ; Alexa 488 molecular probes , No	5749
20 min in secondary antibody -LSB- goat anti-mouse IgG -LRB- H + L -RRB- ; Alexa 488 molecular probes	5749
20 min in secondary antibody -LSB- goat anti-mouse IgG -LRB- H + L -RRB-	5749
20 min	5749
secondary antibody -LSB- goat anti-mouse IgG -LRB- H + L -RRB-	5759
secondary antibody -LSB- goat anti-mouse IgG	5759
secondary antibody -LSB-	5759
H + L	5800
H	5800
L	5804
Alexa 488 molecular probes	5808
Alexa	5808
488 molecular probes	5814
No	5836
A-11029	5840
The sections	5850
Crystal/Mount -LRB- Biomeda , Foster , California , USA -RRB-	5877
Crystal/Mount	5877
Biomeda	5892
Foster	5901
California , USA	5909
a confocal laser microscope -LRB- Zeiss , Berlin , Germany , LSM-510 META/UV -RRB-	5945
a confocal laser microscope	5945
Zeiss	5974
Berlin , Germany	5981
LSM-510 META/UV	5998
Olfactory ensheathing cells	6016
markers	6065
the nonmyelin-forming Schwann cell phenotype , namely , low-affinity p75NGFR -LSB- 6 -RSB-	6084
the nonmyelin-forming Schwann cell phenotype	6084
low-affinity p75NGFR	6138
6 -RSB-	6160
Anterograde	6164
Eight weeks	6184
the spinal cord surgery	6202
four rats -LRB- two each from the olfactory and respiratory mucosa-transplanted groups -RRB-	6227
four rats	6227
two each from the olfactory and respiratory mucosa-transplanted groups	6238
two each	6238
two	6238
each	6242
the olfactory and respiratory mucosa-transplanted groups	6252
ketamine -LRB- 70 mg / kg -RRB- and xylazine -LRB- 8 mg/kg -RRB-	6331
ketamine -LRB- 70 mg / kg -RRB-	6331
ketamine	6331
70 mg	6341
kg	6347
xylazine -LRB- 8 mg/kg -RRB-	6355
xylazine	6355
8 mg/kg	6365
The cranial bone overlying the motor cortex	6375
The cranial bone	6375
the motor cortex	6402
Electrophysiological recording of hindlimb movement	6432
Electrophysiological recording	6432
hindlimb movement	6466
the injection site -LRB- 1 -- 3 mm posterior to bregma and 1 -- 3 mm lateral to bregma -RRB-	6504
the injection site	6504
1	6524
3 mm posterior to bregma and 1 -- 3 mm lateral to bregma	6526
3 mm posterior to bregma	6526
3 mm posterior	6526
bregma	6543
1 -- 3 mm lateral to bregma	6554
1	6554
3 mm lateral to bregma	6556
3 mm lateral	6556
bregma	6571
Eight injections -LRB- four on each side -RRB- of 10 % fluorescence-labeled biotinylated dextran amine -LRB- BDA -RRB- -LRB- Molecular Probes , BDA-10 000 ; Invitrogen , Carlsbad , California , USA -RRB-	6580
Eight injections -LRB- four on each side -RRB-	6580
Eight injections	6580
four on each side	6598
four	6598
each side	6606
10 % fluorescence-labeled biotinylated dextran amine -LRB- BDA -RRB- -LRB- Molecular Probes , BDA-10 000 ; Invitrogen , Carlsbad , California , USA -RRB-	6620
10 % fluorescence-labeled	6620
dextran amine -LRB- BDA -RRB- -LRB- Molecular Probes , BDA-10 000 ; Invitrogen , Carlsbad , California , USA -RRB-	6658
dextran amine -LRB- BDA -RRB-	6658
dextran amine	6658
BDA	6673
Molecular Probes , BDA-10 000 ; Invitrogen , Carlsbad , California , USA	6679
Molecular Probes	6679
BDA-10 000 ; Invitrogen , Carlsbad , California , USA	6697
BDA-10 000	6697
Invitrogen , Carlsbad , California , USA	6709
the motor cortex with a microsyringe -LRB- 8x0 .5 µl -RRB-	6775
the motor cortex	6775
a microsyringe -LRB- 8x0 .5 µl -RRB-	6797
a microsyringe	6797
8x0 .5 µl	6813
8x0	6813
.5 µl	6816
Two weeks	6824
the BDA injection	6840
the rats	6859
4 % paraformaldehyde in 0.1 M phosphate buffer -LRB- pH 7.4 -RRB-	6887
4 % paraformaldehyde	6887
0.1 M phosphate buffer -LRB- pH 7.4 -RRB-	6910
0.1 M phosphate buffer	6910
pH 7.4	6933
The spinal cords	6942
20-µm thick sections on a freezing microtome	7005
20-µm thick sections	7005
a freezing microtome	7029
The sections	7051
a fluorescence microscope	7084
All experimental protocols and procedures for this study	7111
All experimental protocols and procedures	7111
this study	7157
the Animal Ethics Committee of the Osaka University	7185
the Animal Ethics Committee	7185
the Osaka University	7216
Results	7239
1 A statistically signi ¢ cant greater functional recovery in hindlimb usage was observed in the olfactory mucosa-transplanted rats -LRB- OM -RRB- as compared with the respiratory mucosa-transplanted rats -LRB- RM -RRB- 4 weeks after the transplantation -LRB- * -RRB-	7252
1	7252
A statistically signi ¢ cant greater functional recovery in hindlimb usage	7254
A statistically signi ¢ cant greater functional recovery	7254
¢ cant greater	7275
hindlimb usage	7312
the olfactory mucosa-transplanted rats -LRB- OM -RRB-	7343
the olfactory mucosa-transplanted rats	7343
OM	7383
the respiratory mucosa-transplanted rats -LRB- RM -RRB- 4 weeks after the transplantation -LRB- * -RRB-	7404
the respiratory mucosa-transplanted rats -LRB- RM -RRB-	7404
the respiratory mucosa-transplanted rats	7404
RM	7446
4 weeks	7450
the transplantation -LRB- * -RRB-	7464
the transplantation	7464
BBB , Basso , Beattie , and Bresnahan Locomotor Rating Scale .	7489
BBB , Basso , Beattie , and Bresnahan Locomotor	7489
Rating Scale	7534
Fig. 2 Strong expression of p75NGFR -LRB- upper left -RRB- and GFAP -LRB- upper middle -RRB- of p75NGFR is observed in the olfactory mucosa graft at 2 weeks after transplantation ; however , expression of p75NGFR -LRB- lower left -RRB- and GFAP -LRB- lower middle -RRB- is weak in the olfactory mucosa graft at 8 weeks after the transplantation.The p75NGFR merged with the GFAP is OEC.The expression of OEC	7549
Fig.	7549
2 Strong expression of p75NGFR -LRB- upper left -RRB- and GFAP -LRB- upper middle -RRB- of p75NGFR	7554
2 Strong expression	7554
p75NGFR -LRB- upper left -RRB- and GFAP -LRB- upper middle -RRB-	7577
p75NGFR	7577
upper left	7586
GFAP	7602
upper middle	7608
p75NGFR	7625
the olfactory mucosa graft at 2 weeks	7648
the olfactory mucosa graft	7648
2 weeks	7678
transplantation	7692
expression of p75NGFR -LRB- lower left -RRB- and GFAP -LRB- lower middle -RRB-	7718
expression	7718
p75NGFR -LRB- lower left -RRB- and GFAP -LRB- lower middle -RRB-	7732
p75NGFR -LRB- lower left -RRB-	7732
p75NGFR	7732
lower left	7741
GFAP -LRB- lower middle -RRB-	7757
GFAP	7757
lower middle	7763
the olfactory mucosa graft at 8 weeks	7788
the olfactory mucosa graft	7788
8 weeks	7818
the transplantation.The p75NGFR	7832
the GFAP	7876
OEC.The expression of OEC	7888
OEC.The expression	7888
OEC	7910
2 weeks after the transplantation -LRB- upper right -RRB-	7927
2 weeks	7927
the transplantation -LRB- upper right -RRB-	7941
the transplantation	7941
upper right	7962
8 weeks after the transplantation -LRB- lower right -RRB-	7987
8 weeks after the transplantation	7987
8 weeks	7987
the transplantation	8001
lower right	8022
GFAP , glial ¢ brillary acidic protein .	8035
GFAP	8035
glial ¢ brillary acidic protein	8041
glial	8041
¢ brillary acidic protein	8047
Fig.	8074
3 Corticospinal tract study using BDA	8079
3 Corticospinal tract study	8079
BDA	8113
BDA-labeled ¢ bers	8122
BDA-labeled	8122
¢ bers	8134
the rostral segment of the olfactorymucosa-transplanted graft -LSB- -LRB- a -RRB-	8165
the rostral segment	8165
the olfactorymucosa-transplanted graft -LSB- -LRB- a -RRB-	8188
the olfactorymucosa-transplanted graft -LSB-	8188
arrow , -LRB- b -RRB- -RSB- and slightly present in the caudal segment -LSB- -LRB- a -RRB- , arrowhead , -LRB- c -RRB- -RSB- .	8233
arrow	8233
-LRB- b -RRB- -RSB- and slightly present in the caudal segment -LSB- -LRB- a -RRB- , arrowhead , -LRB- c -RRB- -RSB-	8240
and slightly present in the caudal segment -LSB- -LRB- a -RRB- , arrowhead , -LRB- c -RRB- -RSB-	8245
and slightly present	8245
the caudal segment -LSB- -LRB- a -RRB- , arrowhead , -LRB- c -RRB- -RSB-	8269
the caudal segment	8269
-LRB- a -RRB- , arrowhead , -LRB- c -RRB- -RSB-	8289
arrowhead , -LRB- c -RRB- -RSB-	8294
arrowhead	8294
c	8306
Autophagia	8312
two animals in each group	8344
two animals	8344
each group	8359
These animals	8371
3 days	8401
the analysis of this study	8448
the analysis	8448
this study	8464
A greater functional recovery in the hindlimb usage	8476
A greater functional recovery	8476
the hindlimb usage	8509
the olfactory mucosa-transplanted rats -LRB- n = 5 -RRB-	8544
the olfactory mucosa-transplanted rats	8544
n	8584
5	8586
the control rats -LRB- n = 5 -RRB- -LRB- Fig. 1 -RRB-	8606
the control rats -LRB- n = 5 -RRB-	8606
the control rats	8606
n	8624
5	8626
Fig. 1	8630
The recovery of hindlimb movement	8639
The recovery	8639
hindlimb movement	8655
measurable by 4 weeks after the transplantation in the olfactory mucosa-transplanted rats , with continued divergence of the mean BBB scores	8677
4 weeks after the transplantation in the olfactory mucosa-transplanted rats	8691
4 weeks	8691
the transplantation in the olfactory mucosa-transplanted rats	8705
the transplantation	8705
the olfactory mucosa-transplanted rats	8728
continued divergence of the mean	8773
continued divergence	8773
the mean	8797
6 weeks	8823
the transplantation -LRB- Fig. 1 -RRB-	8837
the transplantation	8837
Fig. 1	8858
The expression of p75NGFR	8867
The expression	8867
p75NGFR	8885
the grafts at 2 weeks	8907
the grafts	8907
2 weeks	8921
the olfactory mucosa transplantation	8935
it	8982
the grafts at 8 weeks	8997
the grafts	8997
8 weeks	9011
the transplantation -LRB- Fig. 2 -RRB-	9025
the transplantation	9025
Fig. 2	9046
BDA-labeled fibers	9055
the rostral segment of the graft	9099
the rostral segment	9099
the graft	9122
olfactory mucosa -LRB- Fig. 3a and b -RRB-	9137
olfactory mucosa	9137
Fig. 3a and b	9155
Fig. 3a	9155
b	9167
they	9175
the caudal segment -LRB- Fig. 3a and c -RRB-	9205
the caudal segment	9205
Fig. 3a and c	9225
Fig. 3a	9225
c	9237
No apparent behavioral recovery -LRB- BBB score 0 -- 2 -RRB- or BDA-labeled fibers	9241
No apparent behavioral recovery -LRB- BBB score 0 -- 2 -RRB-	9241
No apparent behavioral recovery	9241
BBB score 0 -- 2	9274
BBB score 0	9274
2	9286
BDA-labeled fibers	9292
the caudal segment of the graft	9328
the caudal segment	9328
the graft	9350
respiratory mucosa	9365
No p75NGFR positive nuclei	9385
No p75NGFR	9385
positive nuclei	9396
the control rats	9428
grafts from respiratory mucosa	9450
grafts	9450
respiratory mucosa	9462
Discussion Olfactory ensheathing cells expressing p75NGFR	9483
Discussion Olfactory ensheathing cells	9483
p75NGFR	9533
the graft at 2 weeks	9567
the graft	9567
2 weeks	9580
transplanta - tion	9594
transplanta	9594
tion	9607
Ensheathing cells	9613
specialized glial cells that associate with the olfactory nerve , surrounding the sensory axons as they leave the olfactory epithelium and accompanying them from the nose to the brain where they synapse with the mitral cells of the olfactory bulb -LSB- 7 -RSB-	9635
specialized glial cells	9635
the olfactory nerve	9679
the sensory axons	9712
they	9733
the olfactory epithelium	9744
them	9786
the nose to the brain	9796
the nose	9796
the brain	9808
they	9824
the mitral cells of the olfactory bulb -LSB- 7 -RSB-	9842
the mitral cells	9842
the olfactory bulb -LSB- 7 -RSB-	9862
the olfactory bulb	9862
7 -RSB-	9882
Two properties of ensheathing cells	9886
Two properties	9886
ensheathing cells	9904
them	9929
ensheathing cells	9949
the central nervous system -LRB- such as Schwann cells and astrocytes , respectively -RRB-	9997
the central nervous system	9997
Schwann cells and astrocytes , respectively	10033
Schwann cells and astrocytes	10033
The second unique property	10078
the fact	10117
a continual neurogenesis	10131
the olfactory epithelium , which produces new sensory neurons throughout adult life	10170
the olfactory epithelium	10170
new sensory neurons	10211
adult life	10242
This property	10254
ensheathing cells in humans -LSB- 8 -RSB-	10288
ensheathing cells	10288
humans -LSB- 8 -RSB-	10309
humans	10309
8 -RSB-	10317
The ensheathing cells	10321
the olfactory nerve	10369
they	10399
the regrowing axons	10424
the region of injury	10447
the region	10447
injury	10461
corticospinal lesions -LSB- 9 -RSB-	10474
corticospinal lesions	10474
9 -RSB-	10497
they	10505
axons	10522
several demyelinating models -LSB- 10,11	10531
several demyelinating models	10531
10,11	10561
the spinal cord	10591
This neurogenesis	10608
a highly regulated process , which is assisted by olfactory ensheathing cells ,	10629
a highly regulated process	10629
olfactory ensheathing cells	10678
the specific role of these cells	10716
the specific role	10716
these cells	10737
A crucial property of ensheathing cells	10766
A crucial property	10766
ensheathing cells	10788
their superior ability to interact with astrocytes	10809
astrocytes	10849
the superficial astrocytic processes , which form the glial scar after lesions ,	10866
the superficial astrocytic processes	10866
the glial scar	10915
lesions	10936
contact	10955
ensheathing cells	10968
the astrocytic processes	10987
their configuration	11019
the glial pathway for axonal regeneration	11047
the glial pathway	11047
axonal regeneration	11069
the glial pathway	11106
axonal regeneration -LSB- 12 -RSB-	11132
axonal regeneration	11132
12 -RSB-	11153
This	11158
the ensheathing cell	11171
an attractive subject for transplantation	11192
an attractive subject	11192
transplantation	11218
spinal cord lesions	11239
the short survival periods examined in this study	11268
the short survival periods	11268
this study	11307
the rate of functional recovery following olfactory mucosa transplantation	11319
the rate	11319
functional recovery following olfactory mucosa transplantation	11331
functional recovery	11331
olfactory mucosa transplantation	11361
that after respiratory mucosa transplantation	11410
that	11410
respiratory mucosa transplantation	11421
our study	11469
p75NGFR expression	11480
the grafts at 2 weeks	11513
the grafts	11513
2 weeks	11527
the transplantation	11541
it	11571
the grafts at 8 weeks	11586
the grafts	11586
8 weeks	11600
the transplantation -LRB- Fig. 3 -RRB-	11614
the transplantation	11614
Fig. 3	11635
This	11644
the axonal regeneration	11669
2 weeks	11710
8 weeks	11735
the transplantation	11749
There	11770
many other advantages of using olfactory tissue	11780
many other advantages	11780
olfactory tissue	11811
it	11836
autologous transplantation	11851
it	11887
a cellular bridge that would join the gap between the transected ends of the spinal cord , thus avoiding the need for an artificial bridge	11904
a cellular bridge	11904
the gap between the transected ends of the spinal cord	11938
the gap	11938
the transected ends of the spinal cord	11954
the transected ends	11954
the spinal cord	11977
the need for an artificial bridge	12008
the need	12008
an artificial bridge	12021
this tissue	12054
a simple biopsy that is performed through the external nares -LSB- 13 -RSB-	12085
a simple biopsy	12085
the external nares -LSB- 13 -RSB-	12127
the external nares	12127
13 -RSB-	12147
